{
    "medicine_id": "2bdf22f621a43eb503f401552097be863867d9ea",
    "platform_id": "DB00085",
    "metadata": {
        "name": "Alka pan Tablets 120 mg Tablet coated",
        "composition": "120 mg Pancrelipase",
        "clinical_particulars": {
            "therapeutic_indications": "The use of pancrelipase amylase is part of the pancreatic enzyme replacement therapy This therapy is indicated for the treatment of pancreatic insufficiency attributed to cystic fibrosis chronic pancreatitis or any other medically defined pancreatic disease that might require it A32721 A32736 Pancreatic diseases are associated with the deterioration of pancreatic parenchyma and of the dual physiological functions of the pancreas Once established pancreatic insufficiency results in malnutrition weight loss and steatorrhea A32723",
            "contraindications": {
                "disease": "The studies of the toxicology of pancrelipase are not needed as this drug has been used clinically for a long time L1770 Clinical overdose studies proved no effect on lungs pancreas liver and kidneys but it can produce symptoms such as diarrhea or stomach upset Carcinogenicity studies have not shown any increased incidence with the use of pancrelipase As pancrelipase is not absorbed the effect on fetal development or reproduction is not expected L2528",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The major maldigestion malabsorption problems arise from incomplete fat digestion In clinical trials the administration of pancrelipase as a mixture of amylase lipase and protease demonstrated a significant improvement in the coefficient of fat absorption and nitrogen absorption These effects are accompanied by increased in body weight and body mass index A32721",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00325",
                        "description": "Pancrelipase can cause a decrease in the absorption of Nitroprusside resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Pancrelipase can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Pancrelipase can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferumoxides resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferric sulfate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11210",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferrous bisglycinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Pancrelipase can cause a decrease in the absorption of Gleptoferron resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11576",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferric oxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Pancrelipase can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Pancrelipase can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13569",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferrous chloride resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferric cation resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14491",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Pancrelipase can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Pancrelipase can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12208",
                        "description": "Pancrelipase can cause a decrease in the absorption of Iron isomaltoside 1000 resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}